New Suicide Assessment Tool Shows Potential in the ED.

Published Date: 10 Jun 2023

Patients who are at an immediate risk of suicide may be identified by a cluster of symptoms that is reflected in a new assessment tool.

Read Full News

Latest News

Spain’s Debate Over Obstetric Violence

Health leaders in Spain debate balancing maternal-fetal safety with respectful, informed care, spotlighting birth plans, staffing shortages and calls for public outcome reporting.

Adjunctive Tirofiban Gains Ground in Stroke

Three major studies suggest intravenous or intra-arterial tirofiban may improve reperfusion outcomes without excess safety risk in selected patients with acute ischemic stroke.

Nestle and Danone Face Fresh Scrutiny Over Infant Formula Recalls

Nestle and Danone are facing fresh scrutiny over the handling of infant formula contamination after reports published on Tuesday by French, Belgian and Swiss public ⁠media...

Spanish Authorities Say Homeopathy Is No Better Than Placebo

Authorities report that stronger trial methodology consistently reduces the apparent benefits linked to homeopathic products across conditions.

Declare Climate Change a Public Health Emergency, EU Experts

A European report says the WHO should urgently scale up climate and health action in the face of waning attention.

Certain Gut-Brain Symptoms Transcend Anatomic Divisions

An expanded symptom questionnaire identified 10 gastrointestinal symptom clusters in patients with disorders of gut-brain interaction.

Todays Updates

EMA Backs Breast Cancer SERD After FDA No Vote

The recommendation follows phase 3 data showing longer progression-free survival when patients switched to camizestrant plus a CDK4/6 inhibitor.

Datopotamab Deruxtecan Earns New Breast Cancer Indication

The antibody drug conjugate was approved by the FDA for certain patients with triple-negative breast cancer.

Todays Updates

EMA Backs Breast Cancer SERD After FDA No Vote

The recommendation follows phase 3 data showing longer progression-free survival when patients switched to camizestrant plus a CDK4/6 inhibitor.

Datopotamab Deruxtecan Earns New Breast Cancer Indication

The antibody drug conjugate was approved by the FDA for certain patients with triple-negative breast cancer.

Latest News

Health leaders in Spain debate balancing maternal-fetal safety with respectful, informed care, spotlighting birth plans, staffing shortages and calls for public outcome reporting.

Three major studies suggest intravenous or intra-arterial tirofiban may improve reperfusion outcomes without excess safety risk in selected patients with acute ischemic stroke.

Nestle and Danone are facing fresh scrutiny over the handling of infant formula contamination after reports published on Tuesday by French, Belgian and Swiss public ⁠media...

Authorities report that stronger trial methodology consistently reduces the apparent benefits linked to homeopathic products across conditions.

A European report says the WHO should urgently scale up climate and health action in the face of waning attention.

An expanded symptom questionnaire identified 10 gastrointestinal symptom clusters in patients with disorders of gut-brain interaction.

News All Time

Socioeconomic Gaps Tied to Concussion-Related ED Visits

Socioeconomic disparities determine where patients seek concussion care and patients' likelihood of receiving follow-up care, a study finds.

Balanced Fluid: No Renal Benefit Over Saline in Septic Shock

In children with septic shock, choosing balanced fluid over saline does not appear to change short-term kidney outcomes or survival.

Is Telemedicine Comparable to In-Person Neurology Care?

Virtual neurology care for new patients is comparable to in-person care, with similar 90-day follow-up rates, ED visits, and hospitalizations, a new study shows.

Regenxbio Shares Sink as Safety Concerns Overshadow Muscle Disorder Therapy Trial Win

Regenxbio said on Thursday that its experimental gene therapy for a muscle-wasting disorder met the main goal ⁠in a late-stage study, but its shares plunged 31% in morning...

US Drug Overdose Deaths Dropped for Third Straight Year in 2025, CDC Data Shows

Drug overdose deaths in the United States fell nearly ⁠14% in 2025, federal estimates showed on Wednesday, marking a third ⁠consecutive year of declines.

Common Practice of DOAC Switching After Stroke Challenged

A multicenter, registry-based cohort study showed no short-term benefit of the common practice of switching anticoagulants after a breakthrough ischemic stroke in patients with atrial fibrillation.

Resistant Gut Bacteria May Flag C difficile Infection Risk

Adults colonised with extended-spectrum beta-lactamase-producing bacteria in the intestinal tract may face higher odds of developing Clostridioides difficile infection.

High-Risk Mental Health Patients Left Unmonitored in A&E

A 3-year RCEM programme finds high-risk mental health patients in emergency departments are going unmonitored — though rates have improved significantly since 2023.

Scotland Clears New Bladder Cancer Combination Therapy

The Scottish Medicines Consortium has approved a new first-line combination therapy for restricted use in adults with unresectable or metastatic urothelial cancer.

Acute Extremity Pain in Patient With Cogan's Syndrome Signals Vascular Ischemia

Timely imaging, anticoagulation, and specialist consultations prevented loss of life or limb

Oregon Emergency Physicians Claim Win Against For-Profit Replacements

— Physicians sued their employer over plans to replace them with an out-of-state firm

Advancing Care for Uncomplicated UTIs: Evidence, Equity, and Evolving Treatments

Advancing Care for Uncomplicated UTIs: Evidence, Equity, and Evolving Treatments

HI-PEITHO Kicks Off 'Golden Era' in Pulmonary Embolism

Trial of ultrasound-based, catheter-directed thrombolysis is one of several anticipated studies

We Have a Substance Use Prevention Problem

Having kids hear from people with lived experience can help move the needle

Here's What People Want on 'The Pitt' Season 3

Attention writers on "The Pitt": our audience has suggestions

He Suddenly Couldn't Speak in Space. Astronaut Says Medical Scare Remains a Mystery.

Doctors have ruled out a heart attack

Recommended News For You

CAR-T cell therapy for cancer causes 'brain fog,' study shows

Paging Dr. AI; Myth Busting in Cancer; Oncologists Shine in Malpractice Survey

Study suggests around 40% of postmenopausal hormone positive breast cancers are linked to excess body fat

AI tool automates liver tumor detection and monitoring

New clinical recommendation for local treatment of oligometastatic lung cancer.

Merck enhances its oncology pipeline by means of a strategic alliance with Hengrui.

Study Supports Lactated Ringer Solution for Fluid Resuscitation in SCD

Recommended Articles For You

Beyond the Standard: Personalized Cancer Vaccines and the Dawn of a New Era in Pediatric Oncology 

Unlocking the Secrets of Hemoglobin: Exploring the Wonders of Life-Sustaining Iron Compounds 

Impact of Hormone Therapy Cessation on Tumor Growth: Case Study of Ki-67 Reduction 

Interpreting Iron Studies: What Your Blood Results Really Mean  

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Does pollution cause cancer?

2.

AI is equally capable of reading breast cancer scans as human radiologists.

3.

EVP Beats Cisplatin for Resectable MIBC

4.

New research points out a promising strategy for treating metastatic medulloblastoma

5.

Academics + Pharma = Big Bucks; New CAR-T Warnings; Patients Seek Cancer Tests.

1.

A Closer Look at Breast Cancer: Examining the Ultrasound Images

2.

Unlocking the Secrets of Oral Cancer Staging: A New Approach to Early Detection

3.

Impact of Hormone Therapy Cessation on Tumor Growth: Case Study of Ki-67 Reduction

4.

Unraveling the Mysteries of Lymphoma: A Journey into the Unknown

5.

Refining AML Survival: Prognostic Factors, Therapies, and Stem Cell Strategies Reviewed

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Navigating the Complexities of Ph Negative ALL - Part III

2.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VIII

3.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)

4.

Expert Group meeting with the management of EGFR mutation positive NSCLC - Part III

5.

Virtual Case Study on Pedal Edema and Triple Vessel Disease - An Initiative by Hidoc Dr.

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot